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 Abstract 24 
 25 
Nitrate-rich beetroot juice (BR) supplementation has been shown to increases biomarkers of 26 
nitric oxide bioavailability with implications for the physiological responses to exercise. We 27 
hypothesized that BR supplementation before and during prolonged moderate-intensity exercise 28 
would: maintain an elevated plasma nitrite concentration ([NO2
-
]), attenuate the expected 29 
progressive increase in ?̇?O2 over time, and improve performance in a subsequent time trial (TT). 30 
In a double-blind, randomized, crossover design, 12 males completed 2-h of moderate-intensity 31 
cycle exercise followed by a 100 kJ TT in three conditions: 1) BR before and 1-h into exercise 32 
(BR+BR); 2) BR before and placebo (PL) 1-h into exercise (BR+PL); and 3) PL before and 1-h 33 
into exercise (PL+PL). During the 2-h moderate-intensity exercise bout, plasma [NO2
-
] declined 34 
by ~17% in BR+PL but increased by ~8% in BR+BR such that, at 2-h, plasma [NO2
-
] was 35 
greater in BR+BR than both BR+PL and PL+PL (P<0.05). ?̇?O2 was not different between 36 
conditions over the first 90 min of exercise, but was lower at 120 min in BR+BR (1.73 ± 0.24 37 
L·min
-1
) compared to BR+PL (1.80  0.21 L·min-1; P=0.08) and PL+PL (1.83 ± 0.27 L·min-1; 38 
P<0.01). The decline in muscle [glycogen] over the 2-h exercise bout was attenuated in BR+BR 39 
(~28% decline) compared to BR+PL (~44% decline) and PL+PL (~44% decline; n = 9, P<0.05). 40 
TT performance was not different between conditions (P>0.05). BR
 
supplementation before and 41 
during prolonged moderate-intensity exercise attenuated the progressive rise in ?̇?O2 over time 42 
and appeared to reduce muscle glycogen depletion but did not enhance subsequent TT 43 
performance.  44 
 45 
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 49 
 50 
  51 
 Introduction 52 
 53 
Nitric oxide (NO) is recognized as a ubiquitous signaling molecule fundamental to regulating 54 
many physiological functions including vasodilation (14), skeletal muscle contraction (49), 55 
mitochondrial respiration (8), and glucose uptake (3). In humans, NO bioavailability can be 56 
increased through exogenous consumption of inorganic nitrate (NO3
-
) which can be reduced to 57 
nitrite (NO2
-
) by bacterial NO3
- 
reductases in the oral cavity and further reduced into NO and 58 
other reactive nitrogen species under appropriate physiological conditions (39). In addition to 59 
reducing resting blood pressure (54), dietary NO3
-
 supplementation has been reported to reduce 60 
the O2 cost of exercise (2, 38, 53) and to enhance skeletal muscle contractile function (22, 24, 61 
55), effects which might be expected to result in improved exercise performance.  62 
 63 
Several studies indicate that NO3
- 
supplementation can enhance short duration (<30 min) 64 
exercise performance (1, 2, 11, 35, 48). However, the efficacy of NO3
- 
supplementation in 65 
improving longer duration exercise performance is less clear (6, 11, 12, 34, 57). This disparity in 66 
the efficacy of NO3
-
 supplementation in shorter vs. longer endurance exercise may be related to 67 
the metabolism of NO3
-
 and NO2
-
 during exercise. The pre-exercise elevation in plasma [NO2
-
] 68 
following NO3
-
 supplementation has been shown to be associated with the magnitude of 69 
performance enhancement during long duration cycling (57). However, following NO3
-
 70 
supplementation, plasma [NO2
-
]
 
declines over the course of short duration moderate- and severe-71 
intensity exercise (32, 50), as well as during repeated sprints (51, 52, 59). Indeed, this decline in 72 
plasma [NO2
-
] with time during exercise, which may reflect the use of nitrite as a ‘substrate’ for 73 
NO production, is correlated with enhanced high-intensity exercise performance following NO3
-
 74 
supplementation (52, 59). It is possible, therefore, that long duration endurance exercise results 75 
in a progressive, and perhaps substantial, depletion of plasma [NO2
-
] such that the potential 76 
benefits of NO3
-
 supplementation on performance later in exercise are no longer elicited (12, 57). 77 
Ingesting NO3
- 
during longer duration exercise might maintain plasma [NO2
-
] at an elevated level 78 
and provide the potential for performance to be improved.  79 
 80 
During prolonged, constant-work-rate exercise, an upward drift in pulmonary O2 uptake (?̇?O2) is 81 
typically observed (9, 25). The O2 cost of such exercise may increase with time due to a shift in 82 
 substrate utilization towards fat oxidation, a progressive recruitment of type II muscle fibers, or a 83 
decline in skeletal muscle mitochondrial and/or contractile efficiency (29). Muscle glycogen 84 
depletion during prolonged exercise may also contribute to the loss of efficiency over time (43). 85 
Dietary NO3
- 
supplementation has the potential to lower O2 demand during prolonged exercise 86 
(2, 27). Specifically, NO3
- 
supplementation has been reported to enhance the mitochondrial P/O 87 
ratio (37; cf. 55) and to reduce the ATP cost of muscle force production (1). In animal studies, 88 
NO3
- 
supplementation has been reported to improve intracellular calcium (Ca
2+
) handling and 89 
increase force production at low frequencies of contraction in type II muscle fibers (24) and to 90 
lead to preferential blood flow (and O2) distribution to type II muscle (15, 16). Given that: 1) 91 
fatigue development and the progressive increase in ?̇?O2 during prolonged exercise may be 92 
related, at least in part, to the recruitment of type II muscle fibers (33); and that 2) NO3
-
 93 
supplementation positively impacts muscles comprised predominantly of type II fibers (28); it is 94 
possible that ingesting NO3
-
 during as well as before such exercise may be better than pre-95 
exercise NO3
-
 ingestion alone in limiting fatigue development, minimizing ?̇?O2 and enhancing 96 
performance. 97 
 98 
Another mechanism by which NO3
- 
supplementation might potentially alter the O2 cost of 99 
exercise is via effects on carbohydrate metabolism. NO has been shown to play an important role 100 
in regulating skeletal muscle glucose uptake (3). Wylie et al. (59) reported lower blood [glucose] 101 
during high-intensity intermittent exercise following NO3
- 
supplementation, which might suggest 102 
enhanced skeletal muscle glucose uptake; however, this was not confirmed during longer 103 
duration moderate-intensity exercise (6). It therefore remains unclear whether dietary NO3
-
 104 
supplementation before, and especially during, prolonged exercise can affect carbohydrate 105 
metabolism or muscle glycogen utilization. A lower metabolic cost of exercise as reflected by a 106 
lower ?̇? O2 and/or increased muscle glucose uptake from the blood might reduce muscle 107 
glycogen utilization during prolonged exercise and enhance endurance performance.     108 
 109 
The purpose of the present study was, therefore, to investigate whether ingestion of NO3
-
-rich 110 
beetroot juice (BR) before, and also during, 2 h of moderate-intensity cycle exercise influences 111 
physiological responses and improves performance in a subsequent target-work (100 kJ) cycling 112 
performance test relative to a placebo condition. We hypothesized that BR supplementation 113 
 before and during 2-h moderate-intensity exercise would: 1) preserve an elevated plasma [NO2
-
]; 114 
2) attenuate the expected progressive increase in ?̇?O2 with time; 3) reduce muscle glycogen 115 
depletion; and, therefore, 4) improve TT performance. 116 
 117 
Methods 118 
 119 
Subjects  120 
Twelve recreationally-active males (mean ± SD: age 21 ± 1 years, body mass 78 ± 11 kg, height 121 
1.77 ± 0.07 m, ?̇?O2peak, 45 ± 4 mL·kg
-1
min
-1
) volunteered to participate in this study, nine of 122 
whom volunteered for invasive measurements (muscle biopsies and blood sampling). The 123 
protocol, risks, and benefits of participating were explained prior to obtaining written informed 124 
consent. This study was approved by the Institutional Research Ethics Committee and conformed 125 
to the code of ethics of the Declaration of Helsinki.  126 
 127 
Experimental overview 128 
Subjects reported to the laboratory on 5 separate occasions over a 5-week period. On the first 129 
visit, subjects completed a ramp incremental exercise test for the determination of ?̇?O2peak and 130 
gas exchange threshold (GET). During the second visit, subjects were familiarized to the 131 
exercise testing procedures, including completion of a moderate-intensity exercise bout (at a 132 
work rate of 80% of the GET) for 30 min before completing a target-work (100 kJ) cycling 133 
performance test designed to simulate a 4-km TT. 134 
 135 
For the duration of the study, subjects were asked to avoid consuming NO3
-
-rich foods such as 136 
spinach, rocket (arugula), kale, and beetroot, and to refrain from taking any other dietary 137 
supplements or using antibacterial mouthwash as the latter affects the commensal bacteria in the 138 
oral cavity, resulting in the inhibition of NO3
-
 reduction into NO2
-
 (21). In a double-blind, 139 
randomized, crossover design, subjects were assigned to receive dietary supplementation for 3 140 
days. On day 3 of each supplementation period (See Supplementation), subjects reported to the 141 
laboratory to complete the experimental protocol. Experimental visits were performed at the 142 
same time of day ( 2-h). Subjects recorded their activity and diet during the 24-h prior to the 143 
first experimental visit and were asked to repeat these for subsequent visits. Subjects were also 144 
 instructed to arrive at the laboratory following a 10-h overnight fast, having avoided strenuous 145 
exercise and alcohol in the 24-h preceding, and caffeine in the 8-h preceding, each experimental 146 
visit. The subjects were provided with a standardized breakfast consisting of 2 porridge oats 147 
sachets (Quaker Oats Ltd, Leicester, UK; containing 54 g of oats, 200 kcal, 4.2 g fat, 31.8 g 148 
carbohydrate, 5.6 g fibre, 6.0 g protein) mixed with 180 mL of water, 1-h prior to exercising. 149 
 150 
Supplementation 151 
Subjects were randomly assigned to three 3-day supplementation periods in which they 152 
consumed 2 x 70 mL doses per day of either NO3
-
-rich BR: (~6.2 mmol NO3
-
 per 70 mL; Beet it, 153 
James White Drinks Ltd., Ipswich, UK) or a NO3
-
-depleted placebo (PL: ~0.04 mmol NO3
- 
per 154 
70 mL; Beet it, James White Drinks Ltd., Ipswich, UK) separated by a 5-day wash-out period. 155 
The three supplementation conditions were: 1) BR supplementation both before and at 1-h into 156 
exercise (BR+BR); 2) BR supplementation before and PL at 1-h into exercise (BR+PL); and 3) 157 
PL before and at 1-h into exercise (PL+PL). Each 70 mL beverage contained 72 kcal energy and 158 
15.4 g of carbohydrate. On the first two days of each supplementation period, subjects consumed 159 
one 70 mL beverage in the morning and one in the evening, whereas on the experimental day, 160 
subjects consumed 2 x 70 mL of their allocated beverage in the morning 2.5-h prior to the 161 
exercise and 1 x 70 mL of their allocated beverage at 1-h into exercise. This 3-day protocol was 162 
chosen to simulate the approach to supplementation that an athlete might take prior to 163 
competition with the time frame for supplement ingestion on the final morning selected because 164 
peak plasma [NO2
-
] occurs ~2-3-h following NO3
-
 intake (54, 59).    165 
 166 
Exercise procedures 167 
All exercise tests were performed on an electronically-braked cycle ergometer (Lode Excalibur 168 
Sport, Groningen, The Netherlands). On the first visit, subjects completed a ramp incremental 169 
test, involving 3 min of baseline cycling at 20 W, after which the work rate was increased by 30 170 
W/min until task failure. Task failure was recorded once the pedal rate fell by >10 rpm below the 171 
target cadence. The self-selected cadence (70-90 rpm) and seat height and handle bar 172 
configuration were recorded and reproduced on subsequent visits. Breath-by-breath pulmonary 173 
gas exchange data were collected continuously during the incremental test and averaged over 10-174 
s periods. ?̇?O2peak and GET were determined as previously described (53). Heart rate (HR) was 175 
 measured during all tests using short-range radio telemetry (Polar S610, Polar Electro, Kempele, 176 
Finland). 177 
 178 
During the experimental visits, subjects performed baseline cycling at 20 W for 3 min. Following 179 
this, subjects completed 2-h of cycling at 80% GET (91 ± 24 W) at their self-selected cadence. A 180 
1-min rest period followed the end of the 2-h bout during which a muscle biopsy was obtained 181 
(see Muscle Biopsy). The 100 kJ TT commenced immediately after the 1-min period. Subjects 182 
were provided with a 5-s countdown prior to the commencement of all cycling trials. The 183 
resistance on the pedals during the TT was set for each individual using the linear mode of the 184 
Lode ergometer so that the subject would attain the power output associated with GET plus 65% 185 
of the difference between GET and peak power output (65%Δ) on reaching a cadence of 90 rpm 186 
(35). Subjects were deprived of visual performance cues and did not receive notification on 187 
elapsed time but they received consistent verbal encouragement for each TT and were informed 188 
when 75, 50, 25 and 10 kJ of work remained to be completed. Pulmonary gas exchange was 189 
measured for discrete 6-min time periods (from 0-6 min, 27-33 min, 60-66 min, 87-93 min, and 190 
114-120 min) during the 2-h exercise bout (the first 2 min of each period was not used in 191 
analysis), and continuously during the TT.    192 
 193 
Measurements 194 
Muscle biopsy 195 
Skeletal muscle samples were obtained from two incisions made in the m. vastus lateralis under 196 
local anesthesia (1% lidocaine) using the percutaneous Bergström needle biopsy technique with 197 
suction (5). Muscle samples were obtained at rest (10 min prior to the start of the 2-h moderate-198 
intensity exercise bout), within 15 s of the completion of the 2-h exercise bout and within 15 s of 199 
the completion of the TT. Muscle samples were immediately snap-frozen in liquid nitrogen 200 
before being stored at -80°C for subsequent analysis.  201 
 202 
Muscle metabolites 203 
Muscle samples were freeze-dried and dissected to remove visible fat, blood, and connective 204 
tissue using forceps. 200 µL of 3 M perchloric acid was added to ~2 mg dry weight (DW) of 205 
muscle tissue. Samples were incubated on ice for 30 min, then centrifuged for 3 min at 4000 206 
 rpm. 170 µL of supernatant was transferred over to a fresh microcentrifuge tube, and 255 µL of 207 
cooled 2 M potassium hydrogen carbonate (KHCO3) was added. This was centrifuged, and the 208 
supernatant was analyzed for [PCr], [ATP], and [lactate] by fluorometric assays as described by 209 
Black et al. (7).  210 
 211 
Muscle glycogen 212 
~ 1 mg DW  muscle tissue was hydrolysed in 500 µL of 1 M hydrochloric acid at 100 °C for 3-h 213 
to release glycosyl units, and immediately measured using an automated glucose analyzer (YSI 214 
2900 Biochemistry Analyzer, Yellow Springs Instruments, Yellow Springs, OH). The precision 215 
of this method of analysis within this physiological range (0.05 to 0.55 mmol/L) was checked by 216 
measuring the glucose concentration across a range of solutions made up using glucose diluted in 217 
hydrochloric acid; the measured vs. expected values lay on the line of identity with an R
2
 of 0.99.  218 
 219 
Blood analysis 220 
Venous blood was sampled at baseline, 30, 60, 90 and 120 min during the 2-h moderate-intensity 221 
exercise bout, and immediately following the completion of the TT. All blood samples were 222 
obtained from a cannula (Insyte-W
TM
 Becton-Dickinson, Madrid, Spain) that was inserted in the 223 
subject’s antecubital vein, and were drawn into 6 mL lithium-heparin vacutainers (Becton-224 
Dickinson, New Jersey, USA). For blood [lactate] and [glucose] analysis, 200 µL of blood was 225 
immediately hemolyzed into 200 µL of cold Triton X-100 buffer solution (Triton X-100, 226 
Amresco, Salon, OH) and then measured using an automated glucose and lactate analyzer (YSI 227 
2300, Yellow Springs Instruments, Yellow Springs, OH). The remaining whole blood samples 228 
were centrifuged within 2 min of collection at 4000 rpm and 4°C for 10 min and then the plasma 229 
was immediately extracted and frozen at -80°C. Before the analysis of plasma [NO3
-
] and [NO2
-
], 230 
samples were deproteinized using cold ethanol precipitation. Specifically, thawed samples were 231 
centrifuged at 14000 g for 10 min, before 200 µL of sample was added to 400 µL of chilled 232 
ethanol and incubated on ice for 30 min. After further centrifugation at 14000 g for 10 min, the 233 
supernatant was removed for the subsequent determination of [NO3
-
] and [NO2
-
] via gas phase 234 
chemiluminescence as described by Wylie et al. (59). 235 
 236 
Statistical Analysis 237 
 A two-way (condition x time) repeated measures analysis of variance (ANOVA) was used to 238 
analyze differences in physiological and performance responses during the 2-h moderate-239 
intensity exercise bout and the TT. Significant main and interaction effects were further explored 240 
using Fisher’s Least Significant Difference test. In addition, one-way repeated measures 241 
ANOVAs were used to determine physiological and performance differences in the mean and 242 
change values from pre- to post- 2h moderate exercise, and post-TT. The relationship between 243 
?̇?O2 and muscle [glycogen] was explored using the Pearson product moment correlation 244 
coefficient. Statistical significance was accepted at P≤0.05. Results are presented as mean ± SD 245 
unless otherwise stated.  246 
 247 
Results 248 
 249 
All subjects reported consuming all servings of each supplement at the correct times and 250 
confirmed that they had maintained their exercise and dietary habits prior to each testing visit. 251 
There were no reports of gastrointestinal distress or discomfort following the ingestion of BR or 252 
PL either before or during exercise.  253 
 254 
Plasma [NO3
-
] and [NO2
-
] 255 
There was an interaction effect (condition x time) (P<0.01), main effect of time (P<0.01), and 256 
main effect of condition (P<0.01) for plasma [NO3
-
] (Fig. 1A). At baseline, plasma [NO3
-
] was 257 
significantly elevated in BR+BR (315  57 µM; P<0.01) and BR+PL (302  88 µM; P<0.01) 258 
compared to PL+PL (16  7 µM). Plasma [NO3
-
] in BR+BR and BR+PL were elevated at all 259 
time points compared to PL+PL. In PL+PL, plasma [NO3
-
] was unchanged throughout exercise. 260 
In BR+PL, plasma [NO3
-
] was unchanged from baseline to 90 min (P>0.05). However, 261 
compared to baseline, plasma [NO3
-
] in BR+PL decreased by ~16% at 120 min (254  56 µM, 262 
P<0.05). In BR+BR, plasma [NO3
-
] was unchanged from baseline to 60 min (317  52 µM; 263 
P>0.05) but then increased by ~41% at 90 min (448  51 µM, P<0.0001) and remained elevated 264 
until 120 min (463  70 µM, P>0.05). Plasma [NO3
-
] was significantly elevated at 90 min, 120 265 
min, and post-TT in BR+BR compared to BR+PL (P<0.01). 266 
 267 
There was an interaction effect (condition x time) (P<0.05) and main effect of condition 268 
 (P<0.01) for plasma [NO2
-
] (Fig. 1B). At baseline, plasma [NO2
-
] was significantly greater in 269 
BR+BR (482  211 nM; P<0.01) and BR+PL (484  188 nM; P<0.01) compared to PL+PL (203 270 
 63 nM), with no significant difference between BR+BR and BR+PL. Plasma [NO2
-
] was 271 
unchanged throughout exercise in PL+PL. In BR+PL, plasma [NO2
-
] tended to decrease by 272 
~17% from baseline to 120 min (P=0.07). In contrast, in BR+BR, plasma [NO2
-
] increased by 273 
~8% from baseline to 120 min. Plasma [NO2
-
] tended to be elevated at 90 min in BR+BR (491  274 
157 nM) compared to BR+PL (405  188 nM, P=0.09), and was significantly elevated at 120 275 
min in BR+BR (519  152 nM) compared to BR+PL (400  158 nM, P<0.05). Plasma [NO2
-
] 276 
fell significantly (by ~35%) from 120 min to post-TT in BR+BR (P<0.001), BR+PL (P<0.01) 277 
and PL+PL (P<0.05).  278 
 279 
Pulmonary gas exchange during prolonged moderate-intensity exercise 280 
?̇?O2 measured at baseline was not different between conditions (P>0.05). There was a main 281 
effect of time (P<0.01) and an interaction effect (condition x time) for ?̇?O2 (P<0.05; Fig. 2A). 282 
Post hoc analyses revealed that the change in ?̇?O2 from 30 min to 120 min (P<0.05) was lower 283 
in BR+BR compared to PL+PL (P<0.05) and tended to be lower compared to BR+PL (P=0.07, 284 
Fig. 2B); there was no difference between BR+PL and PL+PL (P>0.05). At 120 min, ?̇?O2 was 285 
lower in BR+BR compared to PL+PL (P<0.01), and tended to be lower than BR+PL (P=0.08); 286 
(P>0.05). There was a main effect of time on RER (P<0.01), with RER declining from ~0.93 at 287 
30 min to ~0.89 at 120 min, but no effect of condition and no interaction (P>0.05). Mean RER 288 
was not significantly different between conditions at 30 min (PL+PL: 0.93  0.04 vs. BR+PL: 289 
0.92  0.04 vs. BR+BR: 0.93  0.03), 60 min (PL+PL: 0.90  0.03 vs. BR+PL: 0.89  0.02 vs. 290 
BR+BR: 0.89  0.03), 90 min (PL+PL: 0.91  0.04 vs. BR+PL: 0.90  0.06 vs. BR+BR: 0.91  291 
0.04) or 120 min (PL+PL: 0.90  0.04 vs. BR+PL: 0.89  0.03 vs. BR+BR: 0.90  0.04). 292 
Similarly, there was a main effect of time (P<0.05) but no effect of condition or interaction for 293 
HR or minute ventilation. There was a main effect of time (P<0.05) but no effect of condition or 294 
interaction for blood [glucose] (P>0.05; Table 1). There was no effect of time or condition and 295 
no interaction effect for blood [lactate] (P>0.05; Table 1).  296 
 297 
Muscle metabolic variables 298 
 There was a main effect of time (P<0.01) and a trend for an interaction effect (P=0.06) on 299 
muscle [glycogen] measured at baseline, 120 min, and post-TT (Fig. 3). At baseline, there was 300 
no significant difference in muscle [glycogen] between conditions (BR+BR: 383  105 vs. 301 
BR+PL: 383  144 vs. PL+PL: 412  121 mmol·kg-1 DW, P>0.05). Post hoc tests revealed that 302 
in all conditions, muscle [glycogen] was significantly lower at 120 min compared to resting 303 
baseline (P<0.01), and at post-TT compared to 120 min (P<0.01). At 120 min, muscle 304 
[glycogen] tended to be greater in BR+BR (283  103 mmol·kg-1 DW) compared to BR+PL (215 305 
 102 mmol·kg-1 DW; P=0.08) and PL+PL (226  90 mmol·kg-1 DW; P=0.08) There was no 306 
difference between conditions at post-TT (BR+BR: 161  79 vs. BR+PL: 127  65 vs. PL+PL: 307 
132  69 mmol·kg-1 DW, P>0.05). The absolute muscle [glycogen] at 120 min was inversely 308 
correlated with the absolute ?̇?O2 at 120 min (r = -0.71; P<0.01). There was a trend for a main 309 
effect of condition in the change in muscle [glycogen] from baseline to 120 min (P=0.09), where 310 
the ~28% decline in BR+BR was significantly less compared to the ~44% decline in PL+PL 311 
(P<0.05) and tended to be less than the ~44% decline in BR+PL (P=0.07). The change in muscle 312 
[glycogen] from 120 min to post-TT were not significantly different between conditions 313 
(P>0.05).  314 
 315 
There was a main effect of time on muscle [PCr] (P<0.01; Fig 4A.), [ATP] (P<0.01; Fig. 4B) 316 
and [lactate] (P<0.01; Fig. 4C). Baseline muscle [PCr] and [ATP] were not different between 317 
conditions (P>0.05). There was no effect of condition and no interaction for muscle [PCr] or 318 
[ATP] (P>0.05). Post hoc tests revealed that in all conditions, muscle [PCr] declined from 319 
baseline to 120 min (P<0.05), and from 120 min to post-TT (P<0.01). The mean [PCr] tended to 320 
be greater in BR+BR compared to PL+PL (P=0.08) but there was no difference between BR+BR 321 
and BR+PL or between BR+PL and PL+PL (P>0.05). Muscle [ATP] declined significantly from 322 
120 min to post-TT in BR+BR (P<0.01) and BR+PL (P<0.05) but not PL+PL. Muscle [lactate] 323 
was not significantly different between conditions at 120 min but, compared to 120 min, muscle 324 
[lactate] increased significantly post-TT in all conditions (P<0.01).  325 
 326 
TT performance  327 
TT completion time, mean ?̇?O2 and mean power output during the TT were not significantly 328 
different between conditions (all P>0.05, Fig. 5). Similarly, maximal HR, blood [lactate] and 329 
 blood [glucose] were not different between conditions (P>0.05; Table 1).  330 
 331 
Discussion 332 
 333 
This is the first study to investigate the effect of BR ingestion during exercise, in addition to pre-334 
exercise, on the physiological responses to prolonged moderate-intensity exercise, and 335 
subsequent TT performance. The major novel findings of this study were that, compared to pre-336 
exercise BR supplementation alone, a ‘top-up’ dose of BR consumed during exercise: 1) 337 
maintained the elevation of plasma [NO2
-
]; 2) better maintained the lowered O2 cost of exercise; 338 
3) tended to attenuate the fall in muscle [glycogen] over 2-h of moderate-intensity cycling; but, 339 
4) did not alter simulated 4-km TT performance. Although TT performance was not significantly 340 
improved, our findings indicate that the ingestion of BR during prolonged exercise, in addition to 341 
short-term BR supplementation, may attenuate the rise in ?̇?O2 that typically develops during 342 
such exercise.  343 
 344 
Plasma [NO3
-
] and [NO2
-
] during prolonged moderate-intensity exercise 345 
It is well established that pre-exercise BR supplementation elevates resting plasma [NO3
-
] and 346 
[NO2
-
] (2, 32, 53), and the results of the present study were consistent with these previous 347 
reports. After reaching peak values at ~2-3 h following ingestion, plasma [NO2
-
] then declines 348 
with time (54, 59) as well as during exercise (32, 52). Assuming that plasma [NO2
-
] reflects the 349 
potential for O2-independent NO synthesis in the vasculature and skeletal muscle (20, 54), a 350 
decline in plasma [NO2
-
] over time and during exercise may impact on the efficacy of BR 351 
supplementation in long-duration exercise bouts. Changes in plasma [NO2
-
] during exercise may 352 
reflect the utilization of NO2
-
 to produce NO, conversion of NO2
-
 to NO3
-
 or other reactive 353 
nitrogen species, or transport to other body compartments including skeletal muscle (47). In the 354 
present study, when BR was only consumed pre-exercise (i.e., in the BR+PL condition), both 355 
plasma [NO3
-
] (by 16%; P<0.05) and [NO2
-
] (by 17%; P=0.07) declined from baseline to 120 356 
min. However, when BR was also consumed at 60 min into exercise (i.e. in the BR+BR 357 
condition), plasma [NO3
-
] was increased above baseline by 41% at 90 min and 120 min and 358 
plasma [NO2
-
] was increased above baseline by 8% at 120 min (Fig. 1). Plasma [NO2
-
] was 359 
therefore significantly greater at 120 min in BR+BR compared to BR+PL. These results indicate 360 
 that, following pre-exercise BR supplementation, prolonged moderate-intensity exercise can lead 361 
to a substantial reduction in plasma [NO3
-
] and [NO2
-
], but that this decline can be negated by 362 
BR ingestion during exercise. The results of the present study demonstrate, for the first time, that 363 
BR ingestion during exercise can lead to relatively rapid changes in plasma [NO3
-
] and [NO2
-
]. 364 
The pharmacodynamics and pharmacokinetics of plasma [NO3
-
] and [NO2
-
] following dietary 365 
NO3
-
 ingestion have been described at rest (54, 59) but not during exercise, and further research 366 
is warranted to determine whether, and to what extent, the NO3
-
 - NO2
-
 - NO pathway is 367 
impacted by exercise and its sequelae (including, for example, changes in metabolic rate, core 368 
and oral temperature, distribution of cardiac output, and salivary flow rate).  369 
 370 
Influence of BR on metabolic responses during prolonged moderate-intensity exercise 371 
In the present study, ?̇?O2 was not significantly different between conditions until 120 min of 372 
exercise, at which point it was lower in BR+BR compared to BR+PL and PL+PL. The increase 373 
in ?̇?O2 as exercise progressed in BR+PL and PL+PL was therefore attenuated in BR+BR (Fig. 374 
2). An increasing O2 cost of maintaining the same work rate during long-duration exercise may 375 
be related to an increased O2 cost of mitochondrial ATP production and/or an increased ATP 376 
cost of force production and could reflect changes over time in substrate utilization, 377 
mitochondrial function and motor unit recruitment (29).  378 
 379 
Dietary NO3
-
 supplementation has been reported to reduce the O2 cost of exercise in many (1, 2, 380 
36, 37, 38, 53, 56), though not all (6, 52) studies, but the mechanistic basis for this effect is not 381 
fully resolved. Larsen et al. (37) reported that NaNO3 supplementation enhanced mitochondrial 382 
P/O ratio in vitro and found that this was significantly correlated with the reduction in the O2 383 
cost of cycling in vivo. In contrast, Whitfield et al. (56) reported that, while BR reduced the O2 384 
cost of exercise, it did not alter indices of mitochondrial efficiency. Another explanation for a 385 
lower O2 cost of exercise following NO3
-
 supplementation is a reduced ATP cost of muscle 386 
contraction. Consistent with this, it has been reported, using 
31
P magnetic resonance 387 
spectroscopy, that muscle PCr depletion is reduced during exercise following BR
 
388 
supplementation (2, 18). In the present study, muscle [PCr] determined from biopsy samples 389 
tended to be higher at 120 min of moderate-intensity exercise in BR+BR compared to PL+PL 390 
(P=0.08). Given that the depletion of PCr during exercise reflects the energy cost of contraction 391 
 (31), these results suggest that BR
 
supplementation may have reduced the metabolic cost of force 392 
production. For the same mitochondrial P/O, a lower ATP requirement at the same power output 393 
would dictate a lower ?̇?O2 (58).    394 
 395 
It has been reported in rodents (24, 26) and in humans (13, 22, 55), that muscle contractile force 396 
is increased following NO3
- 
supplementation. However, the mechanism responsible for this effect 397 
remains to be elucidated given that modifications to key contractile proteins related to 398 
intracellular Ca
2+
 handling have been observed in rodents (24) but not humans (55). Whitfield et 399 
al. (56) reported an increased emission of hydrogen peroxide following BR supplementation, 400 
suggesting a potential role for redox signaling in augmenting contractile efficiency (17). 401 
Moreover, at least in rodents, BR supplementation preferentially increases blood flow to (15), 402 
and increases microvascular O2 pressure surrounding (16), type II muscle fibers, which could 403 
contribute to enhanced contractile function. It is possible that, collectively, these effects lower 404 
the O2 cost of long-duration exercise by reducing or delaying the recruitment of motor units that 405 
are higher in the recruitment hierarchy and that may be less efficient (4, 29).  406 
 407 
In the present study, we found that muscle glycogen declined by ~28% over 120 min of exercise 408 
in BR+BR, compared to ~44% decline in both BR+PL and PL+PL (Fig. 3). This tendency for 409 
muscle glycogen sparing could be reflective of a reduction in overall metabolic demand (from 410 
mitochondrial and/or contractile efficiency improvements), and therefore a lower absolute 411 
requirement for carbohydrate oxidation. This is supported by the existence of a significant 412 
negative correlation between the absolute ?̇?O2 and muscle [glycogen] measured at 120 min of 413 
exercise. It has been reported that muscle glycogen content is positively correlated with 414 
sarcoplasmic reticulum Ca
2+
 release rate, which may affect skeletal muscle contractile function 415 
(43). The tendency for muscle glycogen sparing in the BR+BR condition of the present study 416 
suggests a possible new mechanism by which dietary NO3
-
 might enhance efficiency during 417 
long-duration exercise, with implications for exercise performance in such events, and is worthy 418 
of further investigation.  419 
 420 
There was no difference in RER or blood [glucose] between conditions in the present study. In 421 
some previous studies, RER has been observed to be slightly (1, 37) or significantly (59) higher 422 
 following NO3
-
 compared to PL supplementation, although most studies have not found 423 
significant differences in RER (2, 6, 12, 53, 56). Wylie et al. (60) reported a lower blood 424 
[glucose] during high-intensity intermittent exercise following BR compared to PL 425 
supplementation and suggested that this may be due to an increased skeletal muscle glucose 426 
uptake. It is possible that this effect is intensity-dependent given that other studies have reported 427 
no effect of BR on glucose handling during moderate-intensity exercise (6, 12). Given that we 428 
did not observe differences between conditions in blood [glucose] or RER, the sparing of muscle 429 
glycogen in BR+BR would appear to be related to a reduced overall muscle metabolic demand as 430 
reflected in the lower O2 cost of exercise. Alternatively, the tendency for muscle [PCr] to be 431 
somewhat better maintained during exercise in BR+BR compared to PL+PL, which is consistent 432 
with the lower ?̇?O2 in BR+BR (1), indicates that muscle energy charge may have been higher 433 
when BR was ingested such that the stimulation of glycogenolysis was reduced (23). In contrast 434 
to our findings, Betteridge et al. (6) reported no effect of pre-exercise BR
 
supplementation on 435 
muscle [glycogen] (or ?̇?O2) during 60 min of moderate-intensity cycling. The reason for this 436 
difference is unclear but, in addition to the longer exercise duration and the inclusion of BR 437 
ingestion during as well as pre-exercise, our subjects consumed 12.4 mmol NO3
-
 per day for 3 438 
days whereas the subjects in the study of Betteridge et al. (6) consumed an acute 8 mmol dose of 439 
NO3
-
 2.5 hours pre-exercise. The dose and duration of NO3
-
 supplementation is one factor that is 440 
likely to influence efficacy (27) since it may influence NO3
-
 and NO2
-
 storage in skeletal muscle 441 
as well as blood (44, 47, 61). Recent studies indicate that rat (47) and human (44) skeletal muscle 442 
has high [NO3
-
] relative to the blood, that the muscle NO3
-
 store decreases substantially during 443 
exercise in rats (46) and that muscle [NO3
-
] can be modulated by dietary NO3
-
 content (19, 44).         444 
 445 
Influence of BR on metabolic responses and performance during TT exercise 446 
Plasma [NO2
-
] declined markedly during the TT (Fig. 1B). This greater rate of decline in plasma 447 
[NO2
-
] from 120 min to post-TT is in contrast to the more gradual decline in plasma [NO2
-
] 448 
observed from baseline to 120 min in the BR+PL condition, which may suggest an exercise-449 
intensity dependency of plasma [NO2
-
] dynamics. Indeed, previous research has reported 450 
significant reductions in plasma [NO2
-
] following high-intensity exercise of shorter duration (32, 451 
50, 52, 60). It is possible that the greater degree of hypoxia and acidosis that would be expected 452 
to develop in skeletal muscle during high-intensity exercise, such as TT, compared to moderate-453 
 intensity exercise, facilitates or dictates a greater reduction of NO2
-
 to NO (42). Moreover, a 454 
greater recruitment of type II muscle fibers, which have a lower microvascular O2 pressure 455 
compared to type I fibers (16), during higher intensity exercise may also result in a greater 456 
reduction of NO2
-
 to NO.  457 
 458 
It is perhaps surprising that, despite evidence that the metabolic cost of the initial long-duration 459 
exercise bout was reduced in BR+BR (i.e. lower end-exercise ?̇?O2 and trends for a sparing of 460 
muscle [PCr] and [glycogen]), subsequent simulated 4-km TT performance was not different 461 
between the three conditions. Our results are consistent, in part, with those of Christensen et al. 462 
(12) who reported that performance in a 400-kcal cycle TT, which began after a 2-h moderate-463 
intensity ‘pre-load’, was not significantly altered by BR compared to PL in elite cyclists (18.3 vs. 464 
18.6 min, respectively). The influence of NO3
- 
supplementation on TT performance is 465 
controversial (10, 11, 12, 34,  35, 41, 45,  50, 57) and whether or not NO3
-
 ingestion is 466 
performance-enhancing appears to depend on factors such as subject training status, the dose and 467 
duration of NO3
-
 supplementation, and the intensity,  duration, and modality of exercise (27). 468 
Positive effects of NO3
-
 supplementation are more likely to be exhibited in tests of exercise 469 
capacity rather than TT efforts (40). When observed, the ergogenic effect of NO3
-
 470 
supplementation on TT performance, while relatively small (~2%; 10, 35, 45, 50), may be 471 
meaningful in terms of competitive performance. However, as is the case for the majority of 472 
putative nutritional ergogenic aids, the magnitude of this effect is within the sensitivity of most 473 
laboratory tests (30) and may be obscured by intrinsic variability in performance as well as 474 
subject motivation. It is possible that the apparently positive effects of BR on some physiological 475 
variables during prolonged exercise that we found were simply too small to impact on TT 476 
performance. However, it is also possible that a greater exercise pre-load, resulting in greater 477 
glycogen depletion, and/or the inclusion of a longer duration TT, or a higher-sensitivity test of 478 
exercise capacity (40), might have enabled the detection of a beneficial effects of BR on exercise 479 
performance. Administering the top-up dose of BR earlier than 60 min and/or increasing the 480 
duration of the moderate-intensity exercise bout might have enabled plasma [NO2
-
] to reach a 481 
higher value prior to the TT and perhaps resulted in a performance benefit.  482 
 483 
Experimental Considerations 484 
 Although there was no significant difference in muscle [glycogen] between conditions at 120 485 
min of exercise, the decline in muscle [glycogen] between resting baseline and 120 min was 486 
significantly attenuated in BR+BR compared to PL+PL. The changes in muscle [PCr] and ?̇?O2 487 
during exercise were also significantly smaller in BR+BR compared to PL+PL. Although 488 
statistical significance was not attained, the changes in muscle [glycogen], muscle [PCr] and ?̇?O2 489 
over time also tended to be smaller in BR+BR compared to BR+PL. The significant inverse 490 
correlation across conditions between the absolute ?̇?O2 and the absolute muscle [glycogen] at 491 
120 min lends confidence to the interpretation that the sparing of muscle glycogen utilization 492 
was related to changes in oxidative metabolic demand following BR ingestion. However, it 493 
should be acknowledged that the extent of the sparing of muscle glycogen utilization between 494 
baseline and 120 min in BR+BR (~100 mmol·kg
-1
 DW) compared to PL+PL (~186 mmol·kg
-1
 495 
DW) and BR+PL (~168 mmol·kg
-1
 DW) was much greater than would be expected based on the 496 
comparatively small differences in ?̇? O2 and [PCr] we measured. There is the possibility, 497 
therefore, that the differences in muscle [glycogen] may have been overestimated in the present 498 
study. Additional studies are required to investigate the influence of pre- and in-exercise NO3
-
 499 
supplementation on changes in muscle [glycogen] in a larger sample and in trained as well as 500 
untrained participants.              501 
 502 
If a glycogen sparing effect of BR ingestion during exercise can be confirmed, this may have 503 
important implications not just for single long-endurance events but also for multi-day endurance 504 
events such as cycle tours and expeditions, wherein muscle [glycogen] may fall progressively 505 
over consecutive days of exercise. It is also possible that consuming BR during arduous 506 
endurance training programs might attenuate fatigue development related to glycogen 507 
availability and enable additional training to be completed.      508 
 509 
Conclusion 510 
A single dose of BR ingested during exercise in addition to pre-exercise BR
 
supplementation 511 
increased plasma [NO3
-
] and preserved an elevated plasma [NO2
-
] during prolonged moderate-512 
intensity exercise. This was associated with an attenuated upward drift in the O2 cost of exercise, 513 
and a tendency for a sparing of muscle glycogen and PCr, effects which might be expected to 514 
predispose to enhanced exercise tolerance. In conclusion, BR supplementation during exercise 515 
 can modulate plasma [NO3
-
] and [NO2
-
] dynamics and attenuate the progressive rise in ?̇?O2 516 
during prolonged moderate-intensity exercise. However, under the conditions of the present 517 
study, subsequent TT performance was not enhanced by BR supplementation. 518 
519 
 References 520 
 521 
1. Bailey SJ, Fulford J, Vanhatalo A, Winyard PG, Blackwell JR, DiMenna FJ, 522 
Wilkerson DP, Benjamin N, Jones AM. Dietary nitrate supplementation enhances 523 
muscle contractile efficiency during knee-extensor exercise in humans. J Appl Physiol 524 
109(1): 135-148, 2010. doi: 10.1152/japplphysiol.00046.2010.  525 
 526 
2. Bailey SJ, Winyard P, Vanhatalo A, Blackwell JR, Dimenna FJ, Wilkerson DP, 527 
Tarr J, Benjamin N, Jones AM. Dietary nitrate supplementation reduces the O2 cost of 528 
low-intensity exercise and enhances tolerance to high-intensity exercise in humans. J 529 
Appl Physiol 107(4): 1144-1155, 2009. doi: 10.1152/japplphysiol.00722.2009.  530 
 531 
3. Balon TW, Nadler JL. Evidence that nitric oxide increases glucose transport in skeletal 532 
muscle. J Appl Physiol 82(1): 359-363, 1997. 533 
 534 
4. Barstow TJ, Jones AM, Nguyen PH, Casaburi R. Influence of muscle fiber type and 535 
pedal frequency on oxygen uptake kinetics of heavy exercise. J Appl Physiol 81(4): 536 
1642-1650, 1996. 537 
 538 
5. Bergstrom J. Muscle electrolytes in man. Scand J Clin Lab Med 14: 511-513, 1962. 539 
 540 
6. Betteridge S, Bescós R, Martorell M, Pons A, Garnham AP, Stathis CC, McConell 541 
GK. No effect of acute beetroot juice ingestion on oxygen consumption, glucose 542 
kinetics, or skeletal muscle metabolism during submaximal exercise in males. J Appl 543 
Physiol 120(4): 391-8, 2016. doi: 10.1152/japplphysiol.00658.2015. 544 
 545 
7. Black MI, Jones AM, Blackwell JR, Bailey SJ, Wylie LJ, McDonagh ST, Thompson 546 
C, Kelly J, Sumners P, Mileva KN, Bowtell JL, Vanhatalo A. Muscle metabolic and 547 
neuromuscular determinants of fatigue during cycling in different exercise intensity 548 
domains. J Appl Physiol (1985). 122(3): 446-459, 2017. doi: 549 
10.1152/japplphysiol.00942.2016.  550 
  551 
8. Brown GC, Cooper CE. Nanomolar concentrations of nitric oxide reversibly inhibit 552 
synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett. 553 
356(2-3): 295-298, 1994. 554 
 555 
9. Brueckner JC, Atchou G, Capelli C, Duvallet A, Barrault D, Jousselin E, Rieu M, 556 
di Prampero PE. The energy cost of running increases with the distance covered. Eur J 557 
Appl Physiol Occup Physiol. 62(6):385-9, 1991. 558 
 559 
10. Cermak NM, Gibala MJ, van Loon LJ. Nitrate supplementation's improvement of 10-560 
km time-trial performance in trained cyclists. Int J Sport Nutr Exerc Metab. 22(1): 64-561 
71, 2012. 562 
 563 
11. Cermak NM, Res P, Stinkens R, Lundberg JO, Gibala MJ, van Loon LJ. No 564 
improvement in endurance performance after a single dose of beetroot juice. Int J Sport 565 
Nutr Exerc Metab. 22(6): 470-478, 2012. 566 
 567 
12. Christensen PM, Nyberg M, Bangsbo J. Influence of nitrate supplementation on VO₂ 568 
kinetics and endurance of elite cyclists. Scand J Med Sci Sports. 23(1): e21-31, 2013. 569 
doi: 10.1111/sms.12005.  570 
 571 
13. Coggan AR, Leibowitz JL, Kadkhodayan A, Thomas DP, Ramamurthy S, Spearie 572 
CA, Waller S, Farmer M, Peterson LR. Effect of acute dietary nitrate intake on 573 
maximal knee extensor speed and power in healthy men and women. Nitric Oxide. 48: 574 
16-21, 2015. doi: 10.1016/j.niox.2014.08.014.  575 
 576 
14. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, Yang BK, 577 
Waclawiw MA, Zalos G, Xu X, Huang KT, Shields H, Kim-Shapiro DB, Schechter 578 
AN, Cannon RO 3rd, Gladwin MT. Nitrite reduction to nitric oxide by 579 
deoxyhemoglobin vasodilates the human circulation. Nat Med. 9(12): 1498-1505, 2003. 580 
 581 
 15. Ferguson SK, Hirai DM, Copp SW, Holdsworth CT, Allen JD, Jones AM, Musch 582 
TI, Poole DC. Impact of dietary nitrate supplementation via beetroot juice on exercising 583 
muscle vascular control in rats. J Physiol. 591(2): 547-57, 2013. doi: 584 
10.1113/jphysiol.2012.243121.  585 
 586 
16. Ferguson SK, Holdsworth CT, Wright JL, Fees AJ, Allen JD, Jones AM, Musch TI, 587 
Poole DC. Microvascular oxygen pressures in muscles comprised of different fiber 588 
types: Impact of dietary nitrate supplementation. Nitric Oxide. 48: 38-43, 2015. doi: 589 
10.1016/j.niox.2014.09.157.  590 
 591 
17. Ferreira LF, Reid MB. Muscle-derived ROS and thiol regulation in muscle fatigue. J 592 
Appl Physiol 104(3): 853-860, 2008. 593 
 594 
18. Fulford J, Winyard PG, Vanhatalo A, Bailey SJ, Blackwell JR, Jones AM. Influence 595 
of dietary nitrate supplementation on human skeletal muscle metabolism and force 596 
production during maximum voluntary contractions. Pflugers Arch. 465(4): 517-528, 597 
2013. doi: 10.1007/s00424-013-1220-5. 598 
 599 
19. Gilliard CN, Lam JK, Cassel KS, Won Park J, Schechter AN, Piknova B. Effect of 600 
dietary nitrate levels on nitrate fluxes in rat skeletal muscle and liver. Nitric Oxide, 601 
submitted. 602 
 603 
20. Gladwin MT, Shelhamer JH, Schechter AN, Pease-Fye ME, Waclawiw MA, Panza 604 
JA, Ognibene FP, Cannon RO 3rd. Role of circulating nitrite and S-nitrosohemoglobin 605 
in the regulation of regional blood flow in humans. Proc Natl Acad Sci U S A. 606 
97(21):11482-11487, 2000. 607 
 608 
21. Govoni M, Jansson EA, Weitzberg E, Lundberg JO. The increase in plasma nitrite 609 
after a dietary nitrate load is markedly attenuated by an antibacterial mouthwash. Nitric 610 
Oxide. 19(4):333-337, 2008. doi: 10.1016/j.niox.2008.08.003.  611 
 612 
 22. Haider G, Folland JP. Nitrate supplementation enhances the contractile properties of 613 
human skeletal muscle. Med Sci Sports Exerc. 46(12):2234-2243, 2014. doi: 614 
10.1249/MSS.0000000000000351. 615 
 616 
23. Hargreaves M, Richter EA. Regulation of skeletal muscle glycogenolysis during 617 
exercise. Can J Sport Sci. 1988 Dec;13(4):197-203. 618 
 619 
24. Hernández A, Schiffer TA, Ivarsson N, Cheng AJ, Bruton JD, Lundberg JO, 620 
Weitzberg E, Westerblad H. Dietary nitrate increases tetanic [Ca2+]i and contractile 621 
force in mouse fast-twitch muscle. J Physiol. 590(15): 3575-3583, 2012. doi: 622 
10.1113/jphysiol.2012.232777.  623 
 624 
25. Hopker JG, O'Grady C, Pageaux B. Prolonged constant load cycling exercise is 625 
associated with reduced gross efficiency and increased muscle oxygen uptake. Scand J 626 
Med Sci Sports. 27(4): 408-417, 2017. doi: 10.1111/sms.12673. 627 
 628 
26. Ivarsson N, Schiffer TA, Hernández A, Lanner JT, Weitzberg E, Lundberg JO, 629 
Westerblad H. Dietary nitrate markedly improves voluntary running in mice. Physiol 630 
Behav. 168: 55-61, 2017. doi: 10.1016/j.physbeh.2016.10.018.  631 
 632 
27. Jones AM. Influence of dietary nitrate on the physiological determinants of exercise 633 
performance: a critical review. Appl Physiol Nutr Metab. 39(9): 1019-1028, 2014. doi: 634 
10.1139/apnm-2014-0036. 635 
 636 
28. Jones AM, Ferguson SK, Bailey SJ, Vanhatalo A, Poole DC. Fiber type-specific 637 
effects of dietary nitrate. Exerc Sport Sci Rev. 2016 Apr;44(2):53-60. doi: 638 
10.1249/JES.0000000000000074.  639 
 640 
29. Jones AM, Grassi B, Christensen PM, Krustrup P, Bangsbo J, Poole DC. Slow 641 
component of VO2 kinetics: mechanistic bases and practical applications. Med Sci Sports 642 
Exerc. 43(11): 2046-2062, 2011. doi: 10.1249/MSS.0b013e31821fcfc1.  643 
 644 
 30. Jonvik KL, Nyakayiru J, van Loon LJ, Verdijk LB. Can elite athletes benefit from 645 
dietary nitrate supplementation? J Appl Physiol (1985). 119(6): 759-761, 2015.  doi: 646 
10.1152/japplphysiol.00232.2015. 647 
 648 
31.  Jubrias SA, Vollestad NK, Gronka RK, Kushmerick MJ. Contraction coupling 649 
efficiency of human first dorsal interosseous muscle. J Physiol. 586(7): 1993-2002, 650 
2008. 651 
 652 
32. Kelly J, Vanhatalo A, Bailey SJ, Wylie LJ, Tucker C, List S, Winyard PG, Jones 653 
AM. Dietary nitrate supplementation: effects on plasma nitrite and pulmonary O2 uptake 654 
dynamics during exercise in hypoxia and normoxia. Am J Physiol Regul Integr Comp 655 
Physiol. 307(7): R920-930, 2014. doi: 10.1152/ajpregu.00068.2014. 656 
 657 
33. Krustrup P, Söderlund K, Mohr M, Bangsbo J. Slow-twitch fiber glycogen depletion 658 
elevates moderate-exercise fast-twitch fiber activity and O2 uptake. Med Sci Sports 659 
Exerc. 2004 Jun;36(6):973-82. 660 
 661 
34. Lane SC, Hawley JA, Desbrow B, Jones AM, Blackwell JR, Ross ML, Zemski AJ, 662 
Burke LM. Single and combined effects of beetroot juice and caffeine supplementation 663 
on cycling time trial performance. Appl Physiol Nutr Metab. 39(9): 1050-1057, 2014. 664 
doi: 10.1139/apnm-2013-0336.  665 
 666 
35. Lansley KE, Winyard PG, Bailey SJ, Vanhatalo A, Wilkerson DP, Blackwell JR, 667 
Gilchrist M, Benjamin N, Jones AM. Acute dietary nitrate supplementation improves 668 
cycling time trial performance. Med Sci Sports Exerc. 43(6): 1125-1131, 2011. doi: 669 
10.1249/MSS.0b013e31821597b4. 670 
 671 
36. Lansley KE, Winyard PG, Fulford J, Vanhatalo A, Bailey SJ, Blackwell JR, 672 
DiMenna FJ, Gilchrist M, Benjamin N, Jones AM. Dietary nitrate supplementation 673 
reduces the O2 cost of walking and running: a placebo-controlled study. J Appl Physiol 674 
110(3): 591-600, 2011. doi: 10.1152/japplphysiol.01070.2010. 675 
 676 
 37. Larsen FJ, Schiffer TA, Borniquel S, Sahlin K, Ekblom B, Lundberg JO, 677 
Weitzberg E. Dietary inorganic nitrate improves mitochondrial efficiency in humans. 678 
Cell Metab. 13(2): 149-159, 2011. doi: 10.1016/j.cmet.2011.01.004. 679 
 680 
38. Larsen FJ, Weitzberg E, Lundberg JO, Ekblom B. Effects of dietary nitrate on 681 
oxygen cost during exercise. Acta Physiol (Oxf). 191(1): 59-66, 2007. 682 
 683 
39. Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in 684 
physiology and therapeutics. Nat Rev Drug Discov. 7(2):156-167, 2008. doi: 685 
10.1038/nrd2466.  686 
 687 
40. McMahon NF, Leveritt MD, Pavey TG. The effect of dietary nitrate supplementation 688 
on endurance exercise performance in healthy adults: a systematic review and meta-689 
analysis. Sports Med. 47(4): 735-756, 2017. doi: 10.1007/s40279-016-0617-7.  690 
 691 
41. McQuillan JA, Dulson DK, Laursen PB, Kilding AE. Dietary nitrate fails to improve 692 
1 and 4 km cycling performance in highly trained cyclists. Int J Sport Nutr Exerc Metab. 693 
27(3): 255-263, 2017. doi: 10.1123/ijsnem.2016-0212.  694 
 695 
42. Modin A, Björne H, Herulf M, Alving K, Weitzberg E, Lundberg JO. Nitrite-696 
derived nitric oxide: a possible mediator of 'acidic-metabolic' vasodilation. Acta Physiol 697 
Scand. 171(1): 9-16, 2001. 698 
 699 
43. Nyakayiru J, Kouw IWK, Cermak NM, Senden JM, van Loon LJC, Verdijk LB. 700 
Sodium nitrate ingestion increases skeletal muscle nitrate content in humans. J Appl 701 
Physiol (1985). 123(3): 637-644, 2017. doi: 10.1152/japplphysiol.01036.2016.  702 
 703 
44. Ørtenblad N, Nielsen J, Saltin B, Holmberg HC. Role of glycogen availability in 704 
sarcoplasmic reticulum Ca2+ kinetics in human skeletal muscle. J Physiol. 589(Pt 3): 705 
711-725, 2011. doi: 10.1113/jphysiol.2010.195982.  706 
 707 
 45. Peeling P, Cox GR, Bullock N, Burke LM. Beetroot juice improves on-water 500 m 708 
time-trial performance, and laboratory-based paddling economy in national and 709 
international-level kayak athletes. Int J Sport Nutr Exerc Metab. 25(3): 278-284, 2015. 710 
doi: 10.1123/ijsnem.2014-0110.  711 
 712 
46. Piknova B, Park JW, Kwan Jeff Lam K, Schechter AN. Nitrate as a source of nitrite 713 
and nitric oxide during exercise hyperemia in rat skeletal muscle. Nitric Oxide. 2016 714 
May 1;55-56:54-61. doi: 10.1016/j.niox.2016.03.005. 715 
 716 
47. Piknova B, Park JW, Swanson KM, Dey S, Noguchi CT, Schechter AN. Skeletal 717 
muscle as an endogenous nitrate reservoir. Nitric Oxide. 47:10-16, 2015. doi: 718 
10.1016/j.niox.2015.02.145.  719 
 720 
48. Porcelli S, Pugliese L, Rejc E, Pavei G, Bonato M, Montorsi M, La Torre A, Rasica 721 
L, Marzorati M. Effects of a short-term high-nitrate diet on exercise performance. 722 
Nutrients. 8(9). pii: E534, 2016. doi: 10.3390/nu8090534. 723 
 724 
49. Reid MB. Role of nitric oxide in skeletal muscle: synthesis, distribution and functional 725 
importance. Acta Physiol Scand. 162(3):401-9, 1998. 726 
 727 
50. Shannon OM, Barlow MJ, Duckworth L, Williams E, Wort G, Woods D, Siervo M, 728 
O'Hara JP. Dietary nitrate supplementation enhances short but not longer duration 729 
running time-trial performance. Eur J Appl Physiol. 117(4): 775-785, 2017. doi: 730 
10.1007/s00421-017-3580-6. 731 
 732 
51. Thompson C, Vanhatalo A, Jell H, Fulford J, Carter J, Nyman L, Bailey SJ, Jones 733 
AM. Dietary nitrate supplementation improves sprint and high-intensity intermittent 734 
running performance. Nitric Oxide. 61: 55-61, 2016. doi: 10.1016/j.niox.2016.10.006.  735 
 736 
52. Thompson C, Wylie LJ, Fulford J, Kelly J, Black MI, McDonagh ST, Jeukendrup 737 
AE, Vanhatalo A, Jones AM. Dietary nitrate improves sprint performance and 738 
 cognitive function during prolonged intermittent exercise. Eur J Appl Physiol. 115(9): 739 
1825-1834, 2015. doi: 10.1007/s00421-015-3166-0. 740 
 741 
53. Vanhatalo A, Bailey SJ, Blackwell JR, DiMenna FJ, Pavey TG, Wilkerson DP, 742 
Benjamin N, Winyard PG, Jones AM. Acute and chronic effects of dietary nitrate 743 
supplementation on blood pressure and the physiological responses to moderate-intensity 744 
and incremental exercise. Am J Physiol Regul Integr Comp Physiol. 299(4): R1121-745 
1131, 2010. doi: 10.1152/ajpregu.00206.2010.  746 
 747 
54. Webb AJ, Patel N, Loukogeorgakis S, Okorie M, Aboud Z, Misra S, Rashid R, 748 
Miall P, Deanfield J, Benjamin N, MacAllister R, Hobbs AJ, Ahluwalia A. Acute 749 
blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via 750 
bioconversion to nitrite. Hypertension. 51(3): 784-790, 2008. doi: 751 
10.1161/HYPERTENSIONAHA.107.103523. 752 
 753 
55. Whitfield J, Gamu D, Heigenhauser GJF, Van Loon LJC, Spriet LL, Tupling AR, 754 
Holloway GP. Beetroot juice increases human muscle force without changing Ca2+ 755 
handling proteins. Med Sci Sports Exerc. 49(10): 2016-2024, 2017. doi: 756 
10.1249/MSS.0000000000001321. 757 
 758 
56. Whitfield J, Ludzki A, Heigenhauser GJ, Senden JM, Verdijk LB, van Loon LJ, 759 
Spriet LL, Holloway GP. Beetroot juice supplementation reduces whole body oxygen 760 
consumption but does not improve indices of mitochondrial efficiency in human skeletal 761 
muscle. J Physiol. 594(2): 421-435, 2016. doi: 10.1113/JP270844.  762 
 763 
57. Wilkerson DP, Hayward GM, Bailey SJ, Vanhatalo A, Blackwell JR, Jones AM. 764 
Influence of acute dietary nitrate supplementation on 50 mile time trial performance in 765 
well-trained cyclists. Eur J Appl Physiol. 112(12): 4127-4134, 2012. doi: 766 
10.1007/s00421-012-2397-6.  767 
 768 
 769 
 58. Wilson DF. Oxidative phosphorylation: regulation and role in cellular and tissue 770 
metabolism. J Physiol. 595(23): 7023-7038, 2017. doi: 10.1113/JP273839.  771 
 772 
59. Wylie LJ, Kelly J, Bailey SJ, Blackwell JR, Skiba PF, Winyard PG, Jeukendrup 773 
AE, Vanhatalo A, Jones AM. Beetroot juice and exercise: pharmacodynamic and dose-774 
response relationships. J Appl Physiol 15(3): 325-336, 2013. doi: 775 
10.1152/japplphysiol.00372.2013.  776 
 777 
60. Wylie LJ, Mohr M, Krustrup P, Jackman SR, Ermιdis G, Kelly J, Black MI, Bailey 778 
SJ, Vanhatalo A, Jones AM. Dietary nitrate supplementation improves team sport-779 
specific intense intermittent exercise performance. Eur J Appl Physiol. 113(7): 1673-780 
1684, 2013. doi: 10.1007/s00421-013-2589-8.  781 
 782 
61. Wylie LJ, Ortiz de Zevallos J, Isidore T, Nyman L, Vanhatalo A, Bailey SJ, Jones 783 
AM. Dose-dependent effects of dietary nitrate on the oxygen cost of moderate-intensity 784 
exercise: Acute vs. chronic supplementation. Nitric Oxide. 57: 30-39, 2016. doi: 785 
10.1016/j.niox.2016.04.004.   786 
 Figure Legends  787 
 788 
Figure 1. Mean  SE plasma nitrate (panel A) and nitrite (panel B) concentrations over 120 min 789 
of moderate-intensity cycle exercise and a subsequent 4-km TT following: PL+PL: placebo 790 
consumed before and during exercise (solid triangle and dotted line); BR+PL: NO3
-
 -rich 791 
beetroot juice consumed before and placebo consumed during exercise (open circle and solid 792 
line); and BR+BR: NO3
-
 -rich beetroot juice before and during exercise (solid circle and solid 793 
line), (n = 9). * = significantly different from PL+PL, ** = BR+BR significantly different from 794 
BR+PL, # = significantly different from 120 min to end of TT in BR+BR,  † = significantly 795 
different from 60 min to end of TT in BR+PL, ‡ = significantly different from 90 min to TT in 796 
PL+PL. 797 
 798 
Figure 2. Mean  SE O2 uptake over 120 min of moderate-intensity cycle exercise (panel A) and 799 
the change in O2 uptake from 30 min to 120 min (panel B) following PL+PL, PL+BR and 800 
BR+BR. * = significantly different in BR+BR compared to PL+PL. 801 
 802 
Figure 3. Mean  SE muscle [glycogen] at rest (PRE), after 120 min moderate-intensity exercise 803 
(POST), and after the 4-km time trial (TT), (n = 9). * = significantly different from PRE to 804 
POST, ** = significantly different from POST to TT. There were no significant differences 805 
between the three conditions at any discrete time point but the change in muscle [glycogen] was 806 
significantly less in BR+BR compared to PL+PL (P<0.05; see text for details). 807 
 808 
Figure 4.  Mean  SE muscle [PCr] (panel A), [ATP] (panel b), and [lactate] (panel C) at rest 809 
(PRE), after 120 min moderate-intensity exercise (POST), and after the 4-km time trial (TT), (n 810 
= 9). * = significantly different from PRE to POST, ** = significantly different from POST to 811 
TT. 812 
 813 
Figure 5. Mean  SE O2 uptake (panel A), power output (panel B), and completion time (panel 814 
C) over the 4-km time trial in PL+PL (black bars), BR+PL (grey bars) and BR+BR (white bars). 815 
Completion times for individual subjects shown in grey lines. 816 
Table 1. Blood [glucose] and [lactate] during 2-h moderate-intensity exercise and at the end 
of a simulated 4-km time trial. 
 
 
 0 30 60 90 120 TT 
Blood 
[glucose] 
      
PL+PL 4.2  0.8 4.0  0.3 4.3  0.5 4.3  0.4 4.0  0.6 4.3  0.8 
BR+PL 3.8  0.9 3.8  0.3 4.0  0.5 4.1  0.6 4.3  0.6 4.7  1.0 
BR+BR 3.9  0.6 3.7  0.6 3.9  0.5 4.2  0.4 4.3  0.5 4.3  0.4 
Blood 
[lactate] 
      
PL+PL 1.1  0.3 1.1  0.2 1.0  0.3 1.1  0.3 1.2  0.4 8.0  2.3* 
BR+PL 1.1  0.4 1.1  0.2 1.0  0.2 1.0  0.2 1.3  0.4 8.0  2.2* 
BR+BR 1.1  0.3 1.1  0.5 1.1  0.4 1.2  0.4 1.3  0.4 7.2  2.0* 
 
Values are mean  SD (n = 9). BR+BR, dietary nitrate supplementation before and during 
exercise; BR+PL, dietary nitrate supplementation before and placebo during exercise; 
PL+PL, placebo before and during exercise. *Significantly different from 120 min (P<0.001). 
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